These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22075318)

  • 21. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
    Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
    Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
    Moore OA; Proudman SM; Goh N; Corte TJ; Rouse H; Hennessy O; Morrisroe K; Thakkar V; Sahhar J; Roddy J; Youssef P; Gabbay E; Nash P; Zochling J; Stevens W; Nikpour M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.
    Johnson DC
    Respir Med; 2000 Jan; 94(1):28-37. PubMed ID: 10714476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
    Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
    Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nailfold Videocapillaroscopy Changes Are Associated With the Presence and Severity of Systemic Sclerosis-Related Interstitial Lung Disease.
    Caetano J; Paula FS; Amaral M; Oliveira S; Alves JD
    J Clin Rheumatol; 2019 Apr; 25(3):e12-e15. PubMed ID: 29782426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of carbon monoxide (CO) single breath pulmonary diffusing capacity with non-rebreathing, open-circuit CO pulmonary diffusing capacity in healthy children.
    Suman OE; Thomas S; Beck KC; Mlcak RP; Herndon DN
    Pediatr Pulmonol; 2006 Nov; 41(11):1095-102. PubMed ID: 16986167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.
    Plastiras SC; Karadimitrakis SP; Ziakas PD; Vlachoyiannopoulos PG; Moutsopoulos HM; Tzelepis GE
    Arthritis Rheum; 2006 Aug; 55(4):598-602. PubMed ID: 16874782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma.
    Tiev KP; Hua-Huy T; Kettaneh A; Allanore Y; Le-Dong NN; Duong-Quy S; Cabane J; Dinh-Xuan AT
    Thorax; 2012 Feb; 67(2):157-63. PubMed ID: 22026971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DLCO versus DLCO/VA as predictors of pulmonary gas exchange.
    Kaminsky DA; Whitman T; Callas PW
    Respir Med; 2007 May; 101(5):989-94. PubMed ID: 17055236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.
    Hudson M; Assayag D; Caron M; Fox BD; Hirsch A; Steele R; Gaudreau-Taillefer R; Tatibouet S; ; Rudski L; Baron M
    Clin Rheumatol; 2013 Oct; 32(10):1467-74. PubMed ID: 23733274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of aging and cardiorespiratory fitness on the lung diffusing capacity response to exercise in healthy humans.
    Coffman KE; Carlson AR; Miller AD; Johnson BD; Taylor BJ
    J Appl Physiol (1985); 2017 Jun; 122(6):1425-1434. PubMed ID: 28336536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM; Stevens WM; Sahhar J; Celermajer D
    Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fibrosis.
    Wheatley CM; Foxx-Lupo WT; Cassuto NA; Wong EC; Daines CL; Morgan WJ; Snyder EM
    J Cyst Fibros; 2011 Jan; 10(1):45-53. PubMed ID: 21050829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of pneumothorax on membrane diffusing capacity and pulmonary capillary blood volume].
    Zeng M; Xie C; Li Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):242-4. PubMed ID: 11775924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raynaud's phenomenon and anti-nuclear antibody are associated with pulmonary function decline in patients with dermatomyositis and polymyositis.
    Park EH; Hwang WC; Lee Y; Lee EY; Lee EB; Song YW; Park JK
    Int J Rheum Dis; 2019 Mar; 22(3):507-515. PubMed ID: 30548402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.
    Liptay MJ; Basu S; Hoaglin MC; Freedman N; Faber LP; Warren WH; Hammoud ZT; Kim AW
    J Surg Oncol; 2009 Dec; 100(8):703-7. PubMed ID: 19798693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.